Date published: 2025-10-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MsrB2 Inhibitors

MsrB2 inhibitors, belonging to a distinctive chemical class, are a group of small molecules designed to selectively target and modulate the activity of the MsrB2 enzyme. These inhibitors have garnered significant attention due to their pivotal role in regulating oxidative stress and cellular redox balance. MsrB2, or methionine sulfoxide reductase B2, is a key member of the methionine sulfoxide reductase (Msr) family of enzymes, which play a fundamental role in cellular defense against oxidative damage. The primary function of MsrB2 is the repair of proteins that have undergone oxidative damage, specifically targeting methionine sulfoxide residues. This repair process involves the conversion of methionine sulfoxide back to methionine, thereby restoring protein functionality.

The chemical class of MsrB2 inhibitors has been developed to interfere with the catalytic activity of MsrB2, effectively modulating its ability to reduce methionine sulfoxide residues in proteins. By selectively inhibiting MsrB2, these compounds offer a unique avenue for investigating the role of oxidative damage in various cellular processes. Researchers have utilized MsrB2 inhibitors as valuable tools in studies related to aging, neurodegenerative diseases, and oxidative stress-related pathways. Understanding the intricate mechanisms of MsrB2 inhibition can provide insights into the broader field of redox biology and its implications for cellular health and function. Consequently, MsrB2 inhibitors continue to be a subject of scientific exploration, contributing to our understanding of the intricate web of cellular responses to oxidative stress.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$196.00
$651.00
(1)

Baricitinib is a Janus kinase (JAK) inhibitor that suppresses JAK1 and JAK2, which are involved in the signaling cascade of MRB2. It helps reduce the immune response by inhibiting cytokine signaling.

Anakinra

143090-92-0sc-507486
10 mg
$795.00
(0)

Anakinra is an IL-1 receptor antagonist that competitively blocks IL-1 receptor binding, disrupting IL-1 signaling and reducing the inflammatory response associated with MRB2.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

Ruxolitinib inhibits JAK1 and JAK2, key components of the JAK-STAT pathway activated in MRB2. By blocking this pathway, it reduces the production of pro-inflammatory cytokines.

Filgotinib

1206161-97-8sc-507393
10 mg
$150.00
(0)

Filgotinib is another JAK1 inhibitor that prevents cytokine signaling via JAK1. By inhibiting JAK1 activity, it mitigates the excessive immune response seen in MRB2.